BDBM441775 US10640533, Identification number CX13-105::US10640533, Table 1.22

SMILES CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)c1cc(CN2CCOCC2)on1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1

InChI Key InChIKey=SJWHEIYVTGRTDQ-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 441775   

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 1.34nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetProteasome subunit beta type-1(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 0.970nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetProteasome subunit beta type-1(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent